Three-year observational study of immediate post-abortion insertion versus menstrual insertion of etonogestrel contraceptive implant

Abstract

Objective This study aimed to estimate the difference in vaginal bleeding pattern, discontinuation rate, and satisfaction between immediate after abortion and menstrual insertions of etonogestrel contraceptive implants. Study design Between May 2013 and November 2015, 66 women were recruited in the abortion group who selected etonogestrel implants as their contraceptive immediately after induced abortion. 84 women who underwent the placement of the etonogestrel implant during their menstrual period were enrolled as the menstrual group. The two groups participated in 3-year follow-up outpatient visits at 1, 6, 12, 24, and 36 months after implantation. The vaginal bleeding pattern, discontinuation rate, satisfaction rate were recorded and compared. Results No woman had pregnancy over the study period of 3 years. The incidence of amenorrhea/infrequent bleeding did not differ between the two groups after 12, 24, and 36 months of implantation (53.0% vs. 58.4%, 47.8% vs. 51.6%, and 48.6% vs. 55.6%, respectively). In the abortion group, the incidences of frequent/prolonged bleeding were 15.1%, 32.6%, and 27.0% after 12, 24, and 36 months of implantation, respectively, while the other group showed 27.3%, 25.8%, and 20.4%, respectively. After 12 and 24 months, the continuation use rates were 69.7% and 56.1% in the abortion group and 73.8% and 64.2% in the menstrual group. The 12-month satisfaction rate between abortion group and menstrual group was 69.6% versus 72.6%. Statistical analyses show that there was no difference in vaginal bleeding pattern, discontinuation rate or satisfaction between the two groups. Conclusions Immediately post-abortion may be also a favorable time to undergo etonogestrel implantation.

Effectiveness and continuation rates of the etonogestrel‐subdermal contraceptive implant versus short‐acting contraceptive methods offered at no cost in Campinas, Brazil

“…We found that all users of the contraceptives in the study were highly satisfied; however, users of the ENG-implant reported a nonsignificant lower satisfaction than the users of the SARC methods up to 1-and 2-years of use, like that reported previously. 16,21 In addition, a China-based study 21 reported a rate of satisfaction of 72% among users of the ENG-implant.…”

Long-Acting Reversible Contraception

“…Implant placement at the time of medication abortion or immediately after early pregnancy uterine aspiration is safe. 32–35 Placing an implant at the time of initiating medication abortion with mifepristone does not change treatment outcome and should be considered based on patient preference and plan for follow-up. 34 Two population studies report decreased repeat pregnancy and abortion in the 2 years after immediate postabortion implant placement.…”